MEDLINE/PubMed
Login
Saving...
Assay Depot
Order research services online
Register
Please, login:
or register to use this function.
Saved Searches
Please, login:
or register to use this function.
Saved Articles
Please, login:
or register to use this function.
Saved Abstracts
Search PubMed
Please, login:
or register to use this function.
Print friendly
Warning message will be there
Did you mean: nat rev drug discov jour
All
1:
Antiplatelet therapies for the treatment of cardiovascular disease.
Nat Rev Drug Discov. 2010 Feb;9(2):154-69
PMID: 20118963 [PubMed - in process]
2:
Therapeutic targeting of chemokine interactions in atherosclerosis.
Nat Rev Drug Discov. 2010 Feb;9(2):141-53
PMID: 20118962 [PubMed - in process]
3:
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.
Nat Rev Drug Discov. 2010 Feb;9(2):107-15
PMID: 20118961 [PubMed - in process]
4:
Ofatumumab.
Nat Rev Drug Discov. 2010 Feb;9(2):101-2
PMID: 20118960 [PubMed - in process]
5:
Pharmaceutical sciences in 2020.
Nat Rev Drug Discov. 2010 Feb;9(2):99-100
PMID: 20118959 [PubMed - in process]
6:
Daniel Vasella.
Nat Rev Drug Discov. 2010 Feb;9(2):98
PMID: 20118958 [PubMed - in process]
7:
Deal watch: M&A activity in 2009.
Nat Rev Drug Discov. 2010 Feb;9(2):95
PMID: 20118956 [PubMed - in process]
8:
Deal watch: Celgene acquires Gloucester pharmaceuticals, gaining approved HDAC inhibitor.
Nat Rev Drug Discov. 2010 Feb;9(2):94
PMID: 20118955 [PubMed - in process]
9:
Deal watch: dipping into Incyte's JAK-pot.
Nat Rev Drug Discov. 2010 Feb;9(2):94
PMID: 20118954 [PubMed - in process]
10:
2009 FDA drug approvals.
Nat Rev Drug Discov. 2010 Feb;9(2):89-92
PMID: 20118952 [PubMed - in process]
11:
Strategies for treating idiopathic pulmonary fibrosis.
Nat Rev Drug Discov. 2010 Feb;9(2):129-40
PMID: 20094055 [PubMed - in process]
12:
Anti-virulence strategies to combat bacteria-mediated disease.
Nat Rev Drug Discov. 2010 Feb;9(2):117-28
PMID: 20081869 [PubMed - in process]
13:
Patent watch: Progress in three key patent disputes in 2009.
Nat Rev Drug Discov. 2010 Jan;9(1):12-3
PMID: 20050395 [PubMed - indexed for MEDLINE]
14:
Orphan products: an emerging trend in drug approvals.
Nat Rev Drug Discov. 2010 Jan;9(1):84
PMID: 20043031 [PubMed - indexed for MEDLINE]
15:
Broadening access to electronic healthcare databases.
Nat Rev Drug Discov. 2010 Jan;9(1):84
PMID: 20043030 [PubMed - indexed for MEDLINE]
16:
Key factors in the discovery and development of new antiepileptic drugs.
Nat Rev Drug Discov. 2010 Jan;9(1):68-82
PMID: 20043029 [PubMed - indexed for MEDLINE]
17:
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.
Nat Rev Drug Discov. 2010 Jan;9(1):57-67
PMID: 20043028 [PubMed - indexed for MEDLINE]
18:
Subcellular targeting strategies for drug design and delivery.
Nat Rev Drug Discov. 2010 Jan;9(1):29-42
PMID: 20043027 [PubMed - indexed for MEDLINE]
19:
Pazopanib.
Nat Rev Drug Discov. 2010 Jan;9(1):17-8
PMID: 20043026 [PubMed - indexed for MEDLINE]
20:
Respiratory syncytial virus market.
Nat Rev Drug Discov. 2010 Jan;9(1):15-6
PMID: 20043025 [PubMed - indexed for MEDLINE]
Print friendly
Top
Warning message will be there
Search PubMed
Please, login:
or register to use this function.
Zapatec.com